BIOMAT Database Logo BIOMAT Database Logo

Are dopaminergic neurons selectively vulnerable to Parkinson's disease? 1993

Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
INSERM U289, Hôpital de la Salpêtrière, Paris, France.

UI MeSH Term Description Entries
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell

Related Publications

Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Embryonic development of selectively vulnerable neurons in Parkinson's disease.
January 2017, NPJ Parkinson's disease,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
February 2001, Neurobiology of disease,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
July 1988, Nature,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Striatal dopaminergic neurons are lost with Parkinson's disease progression.
December 2006, Movement disorders : official journal of the Movement Disorder Society,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Neuromelanin-containing neurons are selectively vulnerable in parkinsonism.
October 1988, Trends in pharmacological sciences,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Evidence That Substantia Nigra Pars Compacta Dopaminergic Neurons Are Selectively Vulnerable to Oxidative Stress Because They Are Highly Metabolically Active.
January 2022, Frontiers in cellular neuroscience,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
NPC1-deficient neurons are selectively vulnerable for statin treatment.
June 2019, Neuropharmacology,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
January 2018, Molecular neurobiology,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
[Grafted dopaminergic neurons are targeted by the disease process in Parkinson's disease].
January 2009, Medecine sciences : M/S,
Y Agid, and M Ruberg, and F Javoy-Agid, and E Hirsch, and R Raisman-Vozari, and S Vyas, and B Faucheux, and P Michel, and A Kastner, and V Blanchard
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.
March 2013, Neurobiology of aging,
Copied contents to your clipboard!